Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 2

recruiting
3 968
countries
28
conditions
2 103

31 trials match your criteria

HIV infection

Not yet recruiting

Durable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial

Registered drug
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Nivolumab

Dyspepsia

Not yet recruiting

Comparing 7-Day and 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Calcium Carbonate

Plasma cell myeloma

Not yet recruiting

Study on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Carfilzomib

Cerebral amyloid angiopathy

Not yet recruiting

Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Acetylcysteine Amide

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine Amide

Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

Investigational
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:SAROGLITAZAR HEMIMAGNESIUM

Study on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel

Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.